IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy

Citation:

Adi Jacob Berger, Gigi, Elinor , Kupershmidt, Lana , Meir, Zohar , Gavert, Nancy , Zwang, Yaara , Prior, Amir , Gilad, Shlomit , Harush, Uzi , Haviv, Izhak , Stemmer, Salomon M, Blum, Galia , Merquiol, Emmanuelle , Mardamshina, Mariya , Kaminski Strauss, Sivan , Friedlander, Gilgi , Bar, Jair , Kamer, Iris , Reizel, Yitzhak , Geiger, Tamar , Pilpel, Yitzhak , Levin, Yishai , Tanay, Amos , Barzel, Baruch , Reuveni, Hadas , and Straussman, Ravid . 10/21/2021. “Irs1 Phosphorylation Underlies The Non-Stochastic Probability Of Cancer Cells To Persist During Egfr Inhibition Therapy”. Nat Cancer ., 2, (10), Pp. 1055-1070. https://www.nature.com/articles/s43018-021-00261-1.